The trademark application was filed by GRIFOLS DIAGNOSTIC SOLUTIONS INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 11, 2021, and it was registered by office on August 18, 2021 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
Relative errors of the trademark registration was recorded on September 21, 2021.
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemical preparations for use in industry
Chemicals used in science
Reagents for scientific purposes
Diagnostics, in particular antigens and antibodies, for scientific purposes
Testing kits for scientific purposes, predominantly consisting of reagents
Proteins, in particular antigens and antibodies
Nucleic acids, in particular for the production of proteins produced by biochemical and/or genetic engineering methods.
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Veterinary preparations
Preparations for medical purposes
Diagnostics, in particular antigens and antibodies, for medical purposes
Pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods
Reagents for medical purposes
Tests and test kits for medical and pharmaceutical purposes.
The mark was filed in class 40 with following description of goods:
Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances
Custom manufacture of biopharmaceuticals
Processing of biopharmaceutical materials for others
Consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances
Custom manufacture of recombinant proteins.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Scientific research and development services
Research in the chemical, medical, and/or biochemical field
Development of pharmaceutical, veterinary and diagnostic substances and products, and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means
Process development services in relation to pharmaceutical, veterinary and diagnostic substances
Technical consultancy in the pharmaceutical, veterinary and diagnostic sector
Services in relation to recombinant protein technology and development.